NCT04282018 2026-02-20Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and TislelizumabBeOne MedicinesPhase 1/2 Completed97 enrolled 43 charts
NCT04172246 2025-11-21Study of Zanubrutinib in Japanese Participants With B-Cell MalignanciesBeOne MedicinesPhase 1/2 Completed55 enrolled